GPT and metabolic syndrome: When the ratio of ALT/AST was treated as a continuous variable (each 1 unit higher), ALT/AST was associated with a 46% increased risk of incident MetS in Model 1 (HR: 1.46 (1.21-1.77)), whereas the association was not significant in Model 2.